U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

MUSA BASJOO WHOLE

MORE DETAILS

V3AYC3JL9Y

structurally diverse
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2012)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f452b457-5ca1-4fdc-a319-eadbc04e953a
First approved in 2012
Source:
21 CFR 347
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f452b457-5ca1-4fdc-a319-eadbc04e953a
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966